Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT04142398

Incidence of HPV Infection and HPV-Associated Disease in Screening Indian Men Who Have Sex With HIV-Positive Men

Investigating Human Papillomavirus (HPV) Infection and HPV-Associated Disease in Indian Men Who Have Sex With Men Who Are HIV-Positive

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
AIDS Malignancy Consortium · Network
Sex
Male
Age
18 Years
Healthy volunteers
Not accepted

Summary

This research trial studies the incidence of human papilloma virus (HPV) infection and HPV-associated disease in screening Indian men who have sex with human immunodeficiency virus (HIV)-positive men. Gathering health information over time from Indian men who have sex with men (MSM) may help doctors determine how many HIV -positive MSM develop new HPV infections and how many HIV-positive MSM have HPV related disease.

Detailed description

PRIMARY OBJECTIVES: I. Determine the prevalence of HPV-associated premalignant lesions in the anus and penis in Indian HIV-seropositive men who have sex with men (MSM). SECONDARY OBJECTIVES: I. Describe risk factors for prevalent premalignant lesions in the anus and penis in Indian HIV-seropositive MSM. II. Describe the prevalence and incidence of penile and anal HPV infection in Indian HIV-seropositive MSM. OUTLINE: Participants receive a questionnaire and undergo a targeted physical and anal clinical exam at months 0, 6, and 12. Participants also undergo a penile skin cell and anal swab at months 0, 6, and 12 for cytology, HPV deoxyribonucleic acid (DNA), and CD4+ T-cell count at months 0 and 6 and HIV viral load testing at months 0 and 12. Participants also undergo high-resolution anoscopy (HRA) and penile clinical exam at month 12.

Conditions

Interventions

TypeNameDescription
OTHERCytology Specimen Collection ProcedureUndergo penile skin cell and anal swab collection
PROCEDUREHigh Resolution Anoscopy with BiopsyUndergo HRA with biopsy
OTHERLaboratory Biomarker AnalysisCorrelative studies
PROCEDUREMedical ExaminationUndergo anal and penile clinical exam
PROCEDUREPhysical ExaminationUndergo targeted physical exam
OTHERQuestionnaire AdministrationAncillary studies

Timeline

Start date
2027-04-30
Primary completion
2029-12-31
Completion
2031-12-31
First posted
2019-10-29
Last updated
2025-06-06

Locations

3 sites across 2 countries: United States, India

Source: ClinicalTrials.gov record NCT04142398. Inclusion in this directory is not an endorsement.